Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis

Terapevticheskii Arkhiv

Volumn 81, Issue 6, 2009, Pages 47-52

  Novikova, D S ^a   Korotaeva, T V ^a   Loginova, E Yu ^a   Popkova, T V ^a   Markelova, E I ^a   Novikov, A A ^a   Alexandrova, E N ^a   MacH, E S ^a   Nasonov, E L ^a  

^a V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

Author keywords

Atherosclerosis; Heart rate variability; Psoriatic arthritis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; MONITORING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSORIATIC ARTHRITIS; TUNICA MEDIA;

ADULT; ARTHRITIS, PSORIATIC; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HEART RATE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TUNICA MEDIA;

EID: 70149093376     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Han C, Robinson D. W., Hackett M. V. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondilitis. J. Rheumatol. 2006; 33: 2167-2172. (Pubitemid 44749774)
2. Kimball A. B., Robinson D. Jr., Wu Y. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008; 217 (I): 27-37. (Pubitemid 351896565)
3. Christophers E. Comorbidities in psoriasis. Clin. Dermatol. 2007; 25 (6): 529-534. (Pubitemid 350087599)
4. Tarn L.S., Tomlinson B., Chu T. T.-W. et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls - the role of inflammation. Rheumatology 2008; 47: 718-723. (Pubitemid 351619219)
5. Kimhi O., Caspi D., Bomstein N. M. et al. Prevalence and risk actors of atherosclerosis in patients with psoriatic arthritis. Semin. Arthr. Rheum. 2007; 36: 203-209. (Pubitemid 46188476)
6. Gonzalez-Juanatey C, Llorca J., Amigo-Diaz E. et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthr. and Rheum. 2007; 57: 1074-1080. (Pubitemid 47237336)
7. Gonzalez-Juanatey C, Llorca J., Miranda-Filloy J. A. et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthr. and Rheum. 2007; 57: 287-293. (Pubitemid 47164092)
8. Cook S, Togni M., Schaub M. et al. High heart rate: a cardiovascular risk factor? Eur. Heart J. 2006; 27: 2387-2393. (Pubitemid 44522142)
9. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
10. Sajadieh A., Nielsen O., Rusmussen V. et al. Increased heart rate and reduced heart rate variability are associated with subclinical inflammation in middle-age and elderly subjects with no apparent heart diseases. Eur. Heart J. 2004; 25: 363-370 (Pubitemid 38391517)
11. Dietrich D., Schindler C, Schwartz J. et al. Heart rate variability in an ageing population and its association with lifestyle and cardiovascular risk factors: results of the SAPALD1A studv Europace 2006; 8: 521-529. (Pubitemid 43985492)
12. Shebab A. M., MacFadyen R. I., McLaren M. et al. Sudden unexpected death in heart failure may be preceded by short term, intraindjvidual increases in inflammation and in autononiic dysfunction: a pilot study. Heart 2004; 90: 1263-1268. (Pubitemid 39433983)
13. Anan F., Takahashi N., Nakagava M. et al. High-sensitive C- reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism 2005; 54 (4): 552-558. (Pubitemid 40410460)
14. Aronson D., Mittleman M. A. Burger,. A. I. Interleulcjn-6 levels are inversely correlated with' heart rate variability in patients with decompensated heart failure. J. Cardiovasc. Electrophysiol. 2001; 12: 294-300. (Pubitemid 32225457)
15. Moll J M Wright V. Psoriatic arthritis. Semin. Arthr. Rheum. 1973; 3: 58-78.
16. Gladman D., Helliwelt P., Mease P. et al. Assessment of patients with psoriatic arthritis. Arthr. and Rheum. 2004; 50: 24-35.
17. Grundy M., Scott G. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation 1999; 100: 1481-1492.
18. Howard G., Sharrett A. R., Heiss G. et al. Carotid artery inti-ma-media thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993; 24: 1297-1304. (Pubitemid 23254630)
19. Lagana B., Gentile R., Vella C. et al. Heart and autonomic nervous system in connective tissue disorders. Recenti Progr. Med. 1997; 88: 579-584. (Pubitemid 128519947)
20. Gladman D. D., Farewell V. T., Wong K., Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthr. and Rheum. 1998; 41: 1103-1110. (Pubitemid 28265412)
21. Sloan R. P., Huang M. H., McCreath H. Cardiac autonomic control and the effects of age, race, and sex: the CARDIA study. Auton. Neurosci. 2008; 30: 78-85.
22. Escalante A., Haas R. W., del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role for comorbidity and systemic inflammation. Arch. Intern. Med. 2005; 167: 1624-1629. (Pubitemid 41124157)
23. von Kanel R., Nelesen R. A., Mills P. J. et al. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav. Immun. 2008; 22: 461-468. (Pubitemid 351451820)
24. Sloan R. P., McCreath H., Tracey K. J. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol. Med. 2007; 13: 178-184. (Pubitemid 46944960)
25. Escarcega R. O., Garcia-Carrasco M., Fuentes-Alexandro S. et al. Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease. Autoimmun. Rev. 2006; 6: 48-53. (Pubitemid 44781092)
26. Shinohara T., Tacahashi N., Yufu K. et al. Role of interieuk-ine-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur. J. Nucl. Med. Mol. Imag. 2008; 35 (9): 1616-1623.
27. Yudkin J. S., Kumari M., Humphries S. E. Inflammation, obesity, stressand coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-214.
28. Stein P. K., Barzilay J. I., Chaves P. H. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study. J. Am. Geriatr. Soc. 2008; 2: 315-321. (Pubitemid 351160704)
29. Neimann A. L., Shin D. B., Wang X. et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J. Am. Acad Dermatol. 2006; 55: 829-835. (Pubitemid 44556851)
30. Holman A. J., Ng E. Heart rate variability predicts anti-tumoi necrosis factor therapy response for inflammatory arthritis. Auton. Neurosci. 2008; 5; 143 (1-2): 58-67.